O

Obsidian Therapeutics

Controlled cell therapies via drug-responsive domains

Senior Accountant

Financial AccountingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A bachelor's degree in Accounting, Finance, or a related field.
  • Five to seven or more years of progressive accounting experience, preferably in biotechnology, pharmaceuticals, or life sciences.
  • Strong knowledge of Generally Accepted Accounting Principles (GAAP) and the ability to research, analyze, document, and apply accounting guidance to non-routine transactions.
  • Ability to independently execute month-end, quarter-end, and year-end close processes and produce accurate, audit-ready financial information.
  • Strong understanding of internal controls over financial reporting, with hands-on experience executing and documenting Sarbanes-Oxley (SOX) controls and supporting external audits.
  • Hands-on experience with treasury and cash management, including bank administration, cash forecasting, payments, reconciliations, and investment activities.
  • Proficiency in enterprise resource planning (ERP) systems, advanced Excel skills, and ability to rapidly learn new systems.
  • Experience with payroll accounting and administration, including payroll reconciliations, payroll-related controls, and coordination with Human Resources and third-party payroll providers.
  • Experience with one or more of NetSuite, Concur, Prendio, FloQast, or ADP Workforce Now.
  • Planning, coordination, and time-management skills.
  • Oral, written, and visual communication skills for effective communication with partners, colleagues, and leadership.
  • Ability to build and maintain productive relationships across the organization.
  • Ability to meet objectives, timelines, and high standards while managing multiple responsibilities in parallel.
  • Ability to adapt to a fast-paced, rapidly developing environment.

Responsibilities

  • Execute month-end, quarter-end, and year-end close processes.
  • Prepare journal entries and reconciliations for assigned areas of ownership.
  • Train colleagues and provide cross-functional support on the company’s procure-to-pay policies and procedures.
  • Enter invoices and run weekly payments.
  • Manage the Concur travel and expense reporting system and process, including policy adherence, and prepare related journal entries.
  • Execute payroll processing, reporting, and accounting.
  • Register and manage state withholding accounts and state tax compliance.
  • Manage day-to-day cash and treasury operations, including monitoring bank balances, cash positioning, transfers, and bank reconciliations.
  • Prepare and maintain short-term cash forecasts, partnering with Finance to ensure adequate liquidity for payroll, operating expenses, clinical activities, and other anticipated cash needs.
  • Ensure compliance with applicable accounting standards, regulatory requirements, and internal controls.
  • Assist with external audits, including preparing audit schedules and documentation.
  • Identify and implement process improvements to enhance efficiency and accuracy in financial operations.

Desired Qualifications

  • Preference is given to accounting experience in the biotechnology, pharmaceutical, or life sciences industry.

About the Company

Obsidian Therapeutics

Controlled cell therapies via drug-responsive domains

Obsidian Therapeutics develops engineered cell and gene therapies for cancer, using its cytoDRiVE pharmacologic operating system to control protein function in cells via drug-responsive domains (DRDs). The system uses FDA-approved small molecules as on/off switches to regulate activity, aiming to improve safety and efficacy of treatments like cytokine-based therapies. Its lead candidate, OBX-115, engineers patient T cells with membrane-bound IL-15 to enhance persistence and potency while avoiding high-dose IL-2 toxicity, enabling TIL therapy for solid tumors such as advanced melanoma and NSCLC. The company is clinical-stage with a focus on oncology, pursuing Phase 1/2 trials and potential commercialization funded by venture capital from investors like GV, Wellington Management, and Bristol Myers Squibb. Unlike conventional cell therapies that rely on static dosing, Obsidian’s platform provides programmable control over therapeutic activity to improve outcomes and limit toxicity.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2015

Recently Posted Jobs

Explore more opportunities at Obsidian Therapeutics

See more jobs